Ontology highlight
ABSTRACT: Introduction
Targeted radiotherapy using the bifunctional chelate approach with 186/188Re(V) is challenging because of the susceptibility of monooxorhenium(V)-based complexes to oxidize in vivo at high dilution. A monoamine-monoamide dithiol (MAMA)-based bifunctional chelating agent was evaluated with both rhenium and technetium to determine its utility for in vivo applications.Methods
A 222-MAMA chelator, 222-MAMA(N-6-Ahx-OEt) bifunctional chelator, and 222-MAMA(N-6-Ahx-BBN(7-14)NH2) were synthesized, complexed with rhenium, radiolabeled with 99mTc and 186Re (carrier added and no carrier added), and evaluated in initial biological distribution studies.Results
An IC50 value of 2.0±0.7nM for natReO-222
SUBMITTER: Demoin DW
PROVIDER: S-EPMC5118109 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature